vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and ISABELLA BANK CORP (ISBA). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $21.2M, roughly 2.0× ISABELLA BANK CORP). ISABELLA BANK CORP runs the higher net margin — 22.2% vs -83.8%, a 105.9% gap on every dollar of revenue. On growth, ISABELLA BANK CORP posted the faster year-over-year revenue change (14.3% vs -59.1%). ISABELLA BANK CORP produced more free cash flow last quarter ($23.3M vs $-59.2M). Over the past eight quarters, ISABELLA BANK CORP's revenue compounded faster (12.6% CAGR vs 10.0%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

The Bank of the Philippine Islands is a universal bank in the Philippines. It is the oldest bank in both the Philippines and Southeast Asia. It is the fourth largest bank in terms of assets, the second largest bank in terms of market capitalization, and one of the most profitable banks in the Philippines.

ARVN vs ISBA — Head-to-Head

Bigger by revenue
ARVN
ARVN
2.0× larger
ARVN
$41.9M
$21.2M
ISBA
Growing faster (revenue YoY)
ISBA
ISBA
+73.4% gap
ISBA
14.3%
-59.1%
ARVN
Higher net margin
ISBA
ISBA
105.9% more per $
ISBA
22.2%
-83.8%
ARVN
More free cash flow
ISBA
ISBA
$82.5M more FCF
ISBA
$23.3M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ISBA
ISBA
Annualised
ISBA
12.6%
10.0%
ARVN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
ISBA
ISBA
Revenue
$41.9M
$21.2M
Net Profit
$-35.1M
$4.7M
Gross Margin
Operating Margin
-104.5%
32.2%
Net Margin
-83.8%
22.2%
Revenue YoY
-59.1%
14.3%
Net Profit YoY
28.7%
17.4%
EPS (diluted)
$-0.48
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
ISBA
ISBA
Q4 25
$21.2M
Q3 25
$41.9M
$20.5M
Q2 25
$18.8M
Q1 25
$188.8M
$18.1M
Q4 24
$59.2M
$18.5M
Q3 24
$102.4M
$18.0M
Q2 24
$76.5M
$17.2M
Q1 24
$25.3M
$16.7M
Net Profit
ARVN
ARVN
ISBA
ISBA
Q4 25
$4.7M
Q3 25
$-35.1M
$5.2M
Q2 25
$5.0M
Q1 25
$82.9M
$3.9M
Q4 24
$-45.1M
$4.0M
Q3 24
$-49.2M
$3.3M
Q2 24
$-35.2M
$3.5M
Q1 24
$-69.4M
$3.1M
Operating Margin
ARVN
ARVN
ISBA
ISBA
Q4 25
32.2%
Q3 25
-104.5%
30.7%
Q2 25
32.8%
Q1 25
37.8%
26.9%
Q4 24
-98.1%
26.0%
Q3 24
-58.9%
21.3%
Q2 24
-63.4%
23.9%
Q1 24
-329.2%
21.8%
Net Margin
ARVN
ARVN
ISBA
ISBA
Q4 25
22.2%
Q3 25
-83.8%
25.6%
Q2 25
26.7%
Q1 25
43.9%
21.9%
Q4 24
-76.2%
21.6%
Q3 24
-48.0%
18.2%
Q2 24
-46.0%
20.3%
Q1 24
-274.3%
18.7%
EPS (diluted)
ARVN
ARVN
ISBA
ISBA
Q4 25
$0.64
Q3 25
$-0.48
$0.71
Q2 25
$0.68
Q1 25
$1.14
$0.53
Q4 24
$-0.63
$0.54
Q3 24
$-0.68
$0.44
Q2 24
$-0.49
$0.46
Q1 24
$-0.97
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
ISBA
ISBA
Cash + ST InvestmentsLiquidity on hand
$787.6M
$26.0M
Total DebtLower is stronger
$600.0K
Stockholders' EquityBook value
$564.4M
$231.4M
Total Assets
$844.3M
$2.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
ISBA
ISBA
Q4 25
$26.0M
Q3 25
$787.6M
$161.3M
Q2 25
$108.6M
Q1 25
$954.3M
$69.2M
Q4 24
$1.0B
$24.5M
Q3 24
$1.1B
$27.4M
Q2 24
$1.2B
$23.6M
Q1 24
$1.2B
$25.2M
Total Debt
ARVN
ARVN
ISBA
ISBA
Q4 25
Q3 25
$600.0K
Q2 25
Q1 25
$700.0K
Q4 24
$800.0K
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Stockholders' Equity
ARVN
ARVN
ISBA
ISBA
Q4 25
$231.4M
Q3 25
$564.4M
$227.4M
Q2 25
$220.5M
Q1 25
$660.1M
$215.6M
Q4 24
$561.7M
$210.3M
Q3 24
$586.0M
$213.0M
Q2 24
$600.2M
$202.2M
Q1 24
$609.7M
$200.7M
Total Assets
ARVN
ARVN
ISBA
ISBA
Q4 25
$2.2B
Q3 25
$844.3M
$2.3B
Q2 25
$2.2B
Q1 25
$1.0B
$2.1B
Q4 24
$1.1B
$2.1B
Q3 24
$1.2B
$2.1B
Q2 24
$1.3B
$2.1B
Q1 24
$1.2B
$2.1B
Debt / Equity
ARVN
ARVN
ISBA
ISBA
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
ISBA
ISBA
Operating Cash FlowLast quarter
$-59.1M
$26.8M
Free Cash FlowOCF − Capex
$-59.2M
$23.3M
FCF MarginFCF / Revenue
-141.3%
110.2%
Capex IntensityCapex / Revenue
0.2%
16.4%
Cash ConversionOCF / Net Profit
5.72×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$36.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
ISBA
ISBA
Q4 25
$26.8M
Q3 25
$-59.1M
$2.7M
Q2 25
$7.8M
Q1 25
$-88.9M
$4.7M
Q4 24
$-84.1M
$19.6M
Q3 24
$-128.0M
$3.6M
Q2 24
$50.3M
$5.5M
Q1 24
$-97.5M
$3.4M
Free Cash Flow
ARVN
ARVN
ISBA
ISBA
Q4 25
$23.3M
Q3 25
$-59.2M
$1.7M
Q2 25
$7.2M
Q1 25
$-89.3M
$3.7M
Q4 24
$-84.4M
$17.5M
Q3 24
$-128.7M
$3.2M
Q2 24
$49.6M
$5.1M
Q1 24
$-97.6M
$2.6M
FCF Margin
ARVN
ARVN
ISBA
ISBA
Q4 25
110.2%
Q3 25
-141.3%
8.5%
Q2 25
38.5%
Q1 25
-47.3%
20.6%
Q4 24
-142.6%
94.6%
Q3 24
-125.7%
17.7%
Q2 24
64.8%
29.8%
Q1 24
-385.8%
15.7%
Capex Intensity
ARVN
ARVN
ISBA
ISBA
Q4 25
16.4%
Q3 25
0.2%
5.0%
Q2 25
3.2%
Q1 25
0.2%
5.5%
Q4 24
0.5%
11.4%
Q3 24
0.7%
2.0%
Q2 24
0.9%
2.4%
Q1 24
0.4%
4.9%
Cash Conversion
ARVN
ARVN
ISBA
ISBA
Q4 25
5.72×
Q3 25
0.52×
Q2 25
1.56×
Q1 25
-1.07×
1.19×
Q4 24
4.91×
Q3 24
1.08×
Q2 24
1.59×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons